These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 26891932)

  • 21. Tumor-targeted nanomedicines for cancer theranostics.
    Arranja AG; Pathak V; Lammers T; Shi Y
    Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 23. Theranostic nanoparticles for cancer and cardiovascular applications.
    Wang D; Lin B; Ai H
    Pharm Res; 2014 Jun; 31(6):1390-406. PubMed ID: 24595494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
    Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
    Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy.
    Luo S; Yang X; Shi C
    Curr Med Chem; 2016; 23(5):483-97. PubMed ID: 26695513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer theranostic applications of lipid-based nanoparticles.
    Tang WL; Tang WH; Li SD
    Drug Discov Today; 2018 May; 23(5):1159-1166. PubMed ID: 29660478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic nanoparticles based cancer therapy: current status and applications.
    Zhang H; Liu XL; Zhang YF; Gao F; Li GL; He Y; Peng ML; Fan HM
    Sci China Life Sci; 2018 Apr; 61(4):400-414. PubMed ID: 29675551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymer-Graphene Nanoassemblies and their Applications in Cancer Theranostics.
    Sivakumar PM; Islami M; Zarrabi A; Khosravi A; Peimanfard S
    Anticancer Agents Med Chem; 2020; 20(11):1340-1351. PubMed ID: 31746307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
    Shi J; Xiao Z; Kamaly N; Farokhzad OC
    Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exogenous/Endogenous-Triggered Mesoporous Silica Cancer Nanomedicine.
    Yang B; Chen Y; Shi J
    Adv Healthc Mater; 2018 Oct; 7(20):e1800268. PubMed ID: 29938917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theranostic application of nanoemulsions in chemotherapy.
    Gorain B; Choudhury H; Nair AB; Dubey SK; Kesharwani P
    Drug Discov Today; 2020 Jul; 25(7):1174-1188. PubMed ID: 32344042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next-generation nanotech meds: Diagnostic and therapeutic applications of non-organic nanoparticles are making their way into clinical use.
    Hunter P
    EMBO Rep; 2017 Jan; 18(1):25-27. PubMed ID: 27979974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zeolites for theranostic applications.
    Khodadadi Yazdi M; Zarrintaj P; Hosseiniamoli H; Mashhadzadeh AH; Saeb MR; Ramsey JD; Ganjali MR; Mozafari M
    J Mater Chem B; 2020 Jul; 8(28):5992-6012. PubMed ID: 32602516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
    Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
    Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copper sulfide: An emerging adaptable nanoplatform in cancer theranostics.
    Poudel K; Gautam M; Jin SG; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2019 May; 562():135-150. PubMed ID: 30904728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards the use of nanoparticles in cancer therapy and imaging.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.